Scientific Letter
Evaluation of the usefulness of a standard multivitamin supplement designed for patients with cystic fibrosis
Valoración de la utilidad de un suplemento multivitamínico estándar diseñado para pacientes con fibrosis quística
a Unidad de Fibrosis Quística, Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, Spain
b Unidad de Fibrosis Quística, Hospital Universitario Ramón y Cajal, Madrid, Spain
c Sección de Neumología Pediátrica, Unidad de Fibrosis Quística, Servicio de Pediatría, Hospital Universitario Ramón y Cajal, Madrid, Spain
d Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, Madrid, Spain
e Servicio de Gastroenterología Pediátrica, Unidad de Fibrosis Quística, Hospital Universitario Ramón y Cajal, Madrid, Spain
f Facultad de Medicina, Universidad de Alcalá de Henares, Madrid, Spain
Read
6477
Timeswas read the article
2199
Total PDF
4278
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 17 | 9 | 26 |
| 2025 5 | 87 | 31 | 118 |
| 2025 4 | 89 | 38 | 127 |
| 2025 3 | 55 | 16 | 71 |
| 2025 2 | 63 | 33 | 96 |
| 2025 1 | 41 | 147 | 188 |
| 2024 12 | 42 | 33 | 75 |
| 2024 11 | 35 | 45 | 80 |
| 2024 10 | 42 | 38 | 80 |
| 2024 9 | 39 | 25 | 64 |
| 2024 8 | 57 | 54 | 111 |
| 2024 7 | 47 | 21 | 68 |
| 2024 6 | 34 | 21 | 55 |
| 2024 5 | 48 | 32 | 80 |
| 2024 4 | 39 | 34 | 73 |
| 2024 3 | 64 | 25 | 89 |
| 2024 2 | 53 | 25 | 78 |
| 2024 1 | 50 | 25 | 75 |
| 2023 12 | 45 | 17 | 62 |
| 2023 11 | 42 | 25 | 67 |
| 2023 10 | 49 | 20 | 69 |
| 2023 9 | 31 | 25 | 56 |
| 2023 8 | 48 | 17 | 65 |
| 2023 7 | 39 | 25 | 64 |
| 2023 6 | 38 | 26 | 64 |
| 2023 5 | 36 | 17 | 53 |
| 2023 4 | 23 | 18 | 41 |
| 2023 3 | 47 | 18 | 65 |
| 2023 2 | 35 | 20 | 55 |
| 2023 1 | 25 | 18 | 43 |
| 2022 12 | 57 | 28 | 85 |
| 2022 11 | 58 | 38 | 96 |
| 2022 10 | 45 | 37 | 82 |
| 2022 9 | 60 | 20 | 80 |
| 2022 8 | 81 | 42 | 123 |
| 2022 7 | 55 | 31 | 86 |
| 2022 6 | 50 | 30 | 80 |
| 2022 5 | 37 | 30 | 67 |
| 2022 4 | 28 | 24 | 52 |
| 2022 3 | 55 | 48 | 103 |
| 2022 2 | 60 | 17 | 77 |
| 2022 1 | 62 | 24 | 86 |
| 2021 12 | 38 | 44 | 82 |
| 2021 11 | 44 | 43 | 87 |
| 2021 10 | 57 | 54 | 111 |
| 2021 9 | 38 | 53 | 91 |
| 2021 8 | 32 | 25 | 57 |
| 2021 7 | 36 | 32 | 68 |
| 2021 6 | 50 | 38 | 88 |
| 2021 5 | 38 | 19 | 57 |
| 2021 4 | 88 | 46 | 134 |
| 2021 3 | 55 | 16 | 71 |
| 2021 2 | 38 | 18 | 56 |
| 2021 1 | 43 | 18 | 61 |
| 2020 12 | 39 | 22 | 61 |
| 2020 11 | 39 | 17 | 56 |
| 2020 10 | 52 | 21 | 73 |
| 2020 9 | 44 | 22 | 66 |
| 2020 8 | 45 | 10 | 55 |
| 2020 7 | 52 | 17 | 69 |
| 2020 6 | 43 | 8 | 51 |
| 2020 5 | 36 | 16 | 52 |
| 2020 4 | 34 | 13 | 47 |
| 2020 3 | 50 | 10 | 60 |
| 2020 2 | 35 | 11 | 46 |
| 2020 1 | 41 | 12 | 53 |
| 2019 12 | 46 | 18 | 64 |
| 2019 11 | 45 | 11 | 56 |
| 2019 10 | 42 | 11 | 53 |
| 2019 9 | 43 | 9 | 52 |
| 2019 8 | 52 | 18 | 70 |
| 2019 7 | 36 | 19 | 55 |
| 2019 6 | 30 | 22 | 52 |
| 2019 5 | 83 | 23 | 106 |
| 2019 4 | 82 | 29 | 111 |
| 2019 3 | 43 | 14 | 57 |
| 2019 2 | 36 | 13 | 49 |
| 2019 1 | 25 | 9 | 34 |
| 2018 12 | 47 | 24 | 71 |
| 2018 11 | 63 | 26 | 89 |
| 2018 10 | 54 | 16 | 70 |
| 2018 9 | 39 | 9 | 48 |
| 2018 8 | 2 | 0 | 2 |
| 2018 6 | 2 | 0 | 2 |
| 2018 5 | 5 | 0 | 5 |
| 2018 4 | 24 | 0 | 24 |
| 2018 3 | 16 | 0 | 16 |
| 2018 2 | 12 | 0 | 12 |
| 2018 1 | 13 | 0 | 13 |
| 2017 12 | 10 | 0 | 10 |
| 2017 11 | 11 | 0 | 11 |
| 2017 10 | 14 | 0 | 14 |
| 2017 9 | 10 | 0 | 10 |
| 2017 8 | 15 | 0 | 15 |
| 2017 7 | 13 | 0 | 13 |
| 2017 6 | 29 | 8 | 37 |
| 2017 5 | 23 | 8 | 31 |
| 2017 4 | 23 | 5 | 28 |
| 2017 3 | 12 | 5 | 17 |
| 2017 2 | 12 | 5 | 17 |
| 2017 1 | 22 | 5 | 27 |
| 2016 12 | 29 | 7 | 36 |
| 2016 11 | 36 | 9 | 45 |
| 2016 10 | 27 | 13 | 40 |
| 2016 9 | 23 | 7 | 30 |
| 2016 8 | 37 | 4 | 41 |
| 2016 7 | 17 | 0 | 17 |
Show all
